Resistell
Founded 2017 · 14 employees on LinkedIn · 3 known investors
Find your way into Resistell
1,446 people in our graph share verified history with the Resistell team — schools, employers, funds. One of them is your warm intro.
Anika Guptaunlockedknows Dr. Alex Sturm · together at Broad Institute of MIT and Harvard (overlapped)
×4knows the team · via Broad Institute of MIT and Harvard
knows the team · via Massachusetts General Hospital
knows the team · via KU Leuven
knows the team · via Massachusetts Institute of Technology
knows the team · via Harvard Medical School
Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings. The Swiss company's IVD product is intended for clinical microbiology use with bacterial pathogens.
Founders & leadership
Resistell was founded in 2017 by Dr. Danuta Cichocka.
DD
Dr. Danuta CichockainCEO, Co-Founder, Board MemberDr. Cichocka is a microbiologist with 20 years of research and product development experience who co-founded and serves as CEO of Resistell, a Swiss diagnostics company that develops nanomotion-based antibiotic susceptibility testing devices for hospital microbiology labs.
GG
Grzegorz GonciarzinCOO
DA
Dr. Alex SturminChief Scientific OfficerDr. Sturm is Chief Scientific Officer at Resistell, a Swiss diagnostics company developing nanomotion-based antibiotic susceptibility testing devices. He has over 15 years of experience in microbiology, infectious diseases, and in vitro diagnostic development, with expertise in bacterial physiology and clinical study management.
MB
Martin BirkinCFOMartin Birk is a CFO and biotech entrepreneur with over 16 years of experience in life sciences, medtech, and regulated startups, including roles in fundraising, financial operations, and M&A strategy. He is co-founder and CEO of TransHeps AG, a company developing diagnostic tools for liver cell-based testing.
Investors · 3
In the news
Frequently asked questions
- What does Resistell do?
- Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings. The Swiss company's IVD product is intended for clinical microbiology use with bacterial pathogens.
- Who founded Resistell?
- Resistell was founded by Dr. Danuta Cichocka in 2017.
- Who are Resistell's investors?
- Resistell's investors include Alpana Ventures, OCCIDENT, TRUMPF Venture.